Eculizumab (Soliris®) Injectable Medication Precertification Request (All fields must be completed and legible for Precertification Review) Start of treatment: Start date - Paroxysmal nocturnal hemoglobinuria - Document - PDFSEARCH.IO

First Page	Meta Content
	Eculizumab (Soliris®) Injectable Medication Precertification Request (All fields must be completed and legible for Precertification Review) Start of treatment: Start date / Add to Reading List Document Date: 2013-02-07 04:18:56 Open Document File Size: 337,16 KB Share Result on Facebook Company Aetna / M.D. D. / / / IndustryTerm fraudulent insurance act / insurance / / MedicalCondition Hemoglobinuria / paroxysmal nocturnal hemoglobinuria / severe aplastic anemia / meningococcal infection / thromboembolism / anemia / serious unresolved Neisseria meningitidis infection / atypical hemolytic uremic syndrome / Hemolytic-uremic syndrome / / Organization Medicare / / / Position Physician / Patient Selected choice Physician / / Product Soliris / Injectable Medication / / Technology cellular telephone / / SocialTag Immunosuppressants Hematopathology Paroxysmal nocturnal hemoglobinuria Aplastic anemia Neisseria meningitidis Medicine Health Eculizumab

Eculizumab (Soliris®) Injectable Medication Precertification Request (All fields must be completed and legible for Precertification Review) Start of treatment: Start date /Add to Reading List